{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:14:20Z","timestamp":1793128460880,"version":"4.5.0"},"reference-count":70,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n Delayed cerebral ischemia (DCI) is a crucial determinant of the prognosis of patients with aneurysmal subarachnoid hemorrhage (aSAH). In Japan, fasudil has traditionally been used to prevent cerebral vasospasm after aSAH. The effectiveness of clazosentan, a selective endothelin receptor A antagonist, in preventing cerebral vasospasm, a significant contributor to DCI, was recently demonstrated. This study aimed to compare the efficacy and safety of perioperative management using clazosentan- and fasudil-based therapies.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n This multicenter, retrospective observational cohort study included 466 patients with aSAH. Patients were categorized into two groups based on the perioperative management administered: clazosentan or fasudil. Data on patient characteristics, treatment outcomes (assessed using the modified Rankin Scale [mRS] at discharge), and complications (including angiographic cerebral vasospasm, vasospasm-related DCI, pulmonary complications, hypotension, brain edema, and de novo intracerebral hemorrhage) were collected. Statistical analyses were conducted using inverse probability of treatment weighting to adjust for selection bias.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n Clazosentan was significantly more effective than fasudil in preventing angiographic cerebral vasospasm (33.7% of fasudil-treated patients had vasospasm vs 15.4% of clazosentan-treated patients, p < 0.001) and vasospasm-related DCI (10.2% fasudil vs 4.4% clazosentan, p = 0.007). This improved effectiveness resulted in significantly better outcomes at discharge (50.5% of fasudil-treated patients had an mRS score of 0\u20132 vs 62.2% of clazosentan-treated patients, p = 0.005). Although clazosentan has been reportedly associated with fluid retention complications, no significant differences in the incidence rates of pulmonary complications or brain edema were found between the groups in this study, likely because of improved fluid management protocols. Clazosentan may also be effective in severe cases or for use in elderly patients aged \u2265 75 years.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Clazosentan outperformed fasudil in preventing cerebral vasospasm and improving overall outcomes in patients with aSAH. Despite initial concerns regarding fluid retention, appropriate perioperative management mitigated these risks, making clazosentan a superior treatment option across different patient groups.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2025.1.jns242509","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T21:49:19Z","timestamp":1747432159000},"page":"624-633","source":"Crossref","is-referenced-by-count":23,"title":["RECOVER study: a multicenter retrospective cohort study and comparison of the efficacy and safety of clazosentan and fasudil in patients with aneurysmal subarachnoid hemorrhage"],"prefix":"10.3171","volume":"143","author":[{"given":"Shinsuke","family":"Muraoka","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Izumi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nishida","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Chr\u00e9tien","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"},{"name":"Department of Neurosurgery, Nagoya Ekisaikai Hospital, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nishihori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsaku","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Maesawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Hospital Organization Nagoya Medical Center, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimato","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Handa City Hospital, Handa, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kinkori","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Okazaki City Hospital, Okazaki, Aichi; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Asai","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kariya Toyota General Hospital, Kariya, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya Ekisaikai Hospital, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Maesawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Shimato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kinkori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyou","family":"Nakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Takasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigekazu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashige","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemasa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"3","key":"b1","series-title":"Cochrane Database Syst Rev","first-page":"CD000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Dorhout Mees SM","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJ, Feigin VL, Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(3):CD000277."},{"issue":"1","key":"b2","series-title":"Cerebrovasc Dis","first-page":"89","article-title":"Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report","volume":"32","author":"Suzuki S","year":"2011","unstructured":"Suzuki S, Sayama T, Nakamura T, Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Cerebrovasc Dis. 2011;32(1):89\u201393."},{"issue":"4","key":"b3","series-title":"J Neurosurg","first-page":"571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya M","year":"1992","unstructured":"Shibuya M, Suzuki Y, Sugita K, Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76(4):571\u2013577."},{"issue":"2","key":"b4","series-title":"Surg Neurol","first-page":"126","article-title":"A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage","volume":"68","author":"Suzuki Y","year":"2007","unstructured":"Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007;68(2):126\u2013132."},{"issue":"10","key":"b5","series-title":"Stroke","first-page":"3403","article-title":"Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis","volume":"40","author":"Kramer A","year":"2009","unstructured":"Kramer A, Fletcher J. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke. 2009;40(10):3403\u20133406."},{"issue":"3","key":"b6","series-title":"Clin Auton Res","first-page":"143","article-title":"Endothelin receptor antagonists and cerebral vasospasm","volume":"14","author":"Zimmermann M","year":"2004","unstructured":"Zimmermann M, Seifert V. Endothelin receptor antagonists and cerebral vasospasm. Clin Auton Res. 2004;14(3):143\u2013145."},{"issue":"9","key":"b7","series-title":"Acta Neurochir (Wien)","first-page":"911","article-title":"Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage\u2014preliminary results from a randomized clinical series","volume":"149","author":"Barth M","year":"2007","unstructured":"Barth M, Capelle HH, M\u00fcnch E, Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage\u2014preliminary results from a randomized clinical series. Acta Neurochir (Wien). 2007;149(9):911\u2013918."},{"issue":"1-2","key":"b8","series-title":"Cerebrovasc Dis","first-page":"59","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura M","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis. 2017;44(1-2):59\u201367."},{"issue":"6","key":"b9","series-title":"J Neurosurg","first-page":"1707","article-title":"Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients","volume":"137","author":"Endo H","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N, Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022;137(6):1707\u20131717."},{"issue":"1","key":"b10","series-title":"Neurosurg Rev","first-page":"195","article-title":"Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study","volume":"46","author":"Muraoka S","year":"2023","unstructured":"Muraoka S, Asai T, Fukui T, Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study. Neurosurg Rev. 2023;46(1):195."},{"key":"b11","series-title":"Front Neurol","first-page":"1413632","article-title":"Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study","volume":"15","author":"Sakata H","year":"2024","unstructured":"Sakata H, Kanoke A, Uchida H, Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study. Front Neurol. 2024;15:1413632."},{"issue":"1","key":"b12","series-title":"Neurosurg Rev","first-page":"113","article-title":"Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan","volume":"47","author":"Mochizuki T","year":"2024","unstructured":"Mochizuki T, Ryu B, Shima S, Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan. Neurosurg Rev. 2024;47(1):113."},{"issue":"9596","key":"b13","series-title":"Lancet","first-page":"1453","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20131457."},{"issue":"6","key":"b14","series-title":"Stroke","first-page":"1711","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly ES Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2012;43(6):1711\u20131737."},{"issue":"10","key":"b15","series-title":"Stroke","first-page":"2391","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen MDI","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20132395."},{"issue":"11","key":"b16","series-title":"J Cereb Blood Flow Metab","first-page":"1761","article-title":"Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia","volume":"28","author":"Vergouwen MDI","year":"2008","unstructured":"Vergouwen MDI, Vermeulen M, Coert BA, Stroes ESG, Roos YBWEM. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(11):1761\u20131770."},{"key":"b17","article-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing","unstructured":"R: A language and environment for statistical computing. R Foundation for Statistical Computing. Accessed February 5, 2025. https:\/\/www.R-project.org\/"},{"issue":"12","key":"b18","series-title":"Curr Atheroscler Rep","first-page":"50","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology","volume":"19","author":"Geraghty JR","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50."},{"issue":"2","key":"b19","series-title":"J Pharmacol Exp Ther","first-page":"322","article-title":"Endothelin ETA receptor blockade, by activating ETB receptors, increases vascular permeability and induces exaggerated fluid retention","volume":"361","author":"Vercauteren M","year":"2017","unstructured":"Vercauteren M, Trensz F, Pasquali A, Endothelin ETA receptor blockade, by activating ETB receptors, increases vascular permeability and induces exaggerated fluid retention. J Pharmacol Exp Ther. 2017;361(2):322\u2013333."},{"issue":"6","key":"b20","series-title":"Stroke","first-page":"653","article-title":"Morphometry of brain parenchymal vessels following subarachnoid hemorrhage","volume":"11","author":"Hart MN","year":"1980","unstructured":"Hart MN. Morphometry of brain parenchymal vessels following subarachnoid hemorrhage. Stroke. 1980;11(6):653\u2013655."},{"issue":"6","key":"b21","series-title":"Neurosurgery","first-page":"1152","article-title":"Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"61","author":"Udoetuk JD","year":"2007","unstructured":"Udoetuk JD, Stiefel MF, Hurst RW, Weigele JB, LeRoux PD. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;61(6):1152\u20131161."},{"issue":"Pt 7","key":"b22","series-title":"Brain","first-page":"1866","article-title":"Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage","volume":"132","author":"Dreier JP","year":"2009","unstructured":"Dreier JP, Major S, Manning A, Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain. 2009;132(Pt 7):1866-1881."},{"issue":"2","key":"b23","series-title":"J Cereb Blood Flow Metab","first-page":"203","article-title":"Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage","volume":"32","author":"Woitzik J","year":"2012","unstructured":"Woitzik J, Dreier JP, Hecht N, Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012;32(2):203\u2013212."},{"issue":"2","key":"b24","series-title":"Brain Hemorrhages","first-page":"62","article-title":"Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage","volume":"5","author":"Suzuki H","year":"2024","unstructured":"Suzuki H, Nakajima H, Ichikawa T, Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage. Brain Hemorrhages. 2024;5(2):62\u201368."},{"issue":"11","key":"b25","series-title":"Stroke","first-page":"3015","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald RL","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S, Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015\u20133021."},{"issue":"7","key":"b26","series-title":"Lancet Neurol","first-page":"618","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald RL","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u2013625."},{"issue":"6","key":"b27","series-title":"Stroke","first-page":"1463","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald RL","year":"2012","unstructured":"Macdonald RL, Higashida RT, Keller E, Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463\u20131469."},{"issue":"3","key":"b28","series-title":"J Neurosurg","first-page":"1006","article-title":"Vasospasm: does it cause infarction and poor outcome?","volume":"134","author":"Weir B","year":"2020","unstructured":"Weir B. Vasospasm: does it cause infarction and poor outcome?. J Neurosurg. 2020;134(3):1006\u20131011."},{"issue":"1","key":"b29","series-title":"AJNR Am J Neuroradiol","first-page":"80","article-title":"Transcranial Doppler velocities and angiographic vasospasm after SAH: a diagnostic accuracy study","volume":"43","author":"Darsaut TE","year":"2022","unstructured":"Darsaut TE, Keough MB, Chan AM, Transcranial Doppler velocities and angiographic vasospasm after SAH: a diagnostic accuracy study. AJNR Am J Neuroradiol. 2022;43(1):80\u201386."},{"issue":"10","key":"b30","series-title":"Neurol Med Chir (Tokyo)","first-page":"679","article-title":"Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine","volume":"51","author":"Zhao J","year":"2011","unstructured":"Zhao J, Zhou D, Guo J, Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo). 2011;51(10):679\u2013683."},{"issue":"1","key":"b31","series-title":"J Neurosurg","first-page":"98","article-title":"REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"142","author":"Mayer SA","year":"2024","unstructured":"Mayer SA, Bruder N, Citerio G, REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2024;142(1):98\u2013109."},{"issue":"1 Suppl","key":"b32","series-title":"J Am Coll Cardiol","first-page":"S78","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst RJ","year":"2009","unstructured":"Barst RJ, Gibbs JSR, Ghofrani HA, Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S78\u2013S84."},{"issue":"12 Suppl S","key":"b33","series-title":"J Am Coll Cardiol","first-page":"81S","article-title":"Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"43","author":"Gali\u00e8 N","year":"2004","unstructured":"Gali\u00e8 N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):81S\u201388S."},{"issue":"Suppl K","key":"b34","series-title":"Eur Heart J Suppl","first-page":"K46","article-title":"The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension","volume":"21","author":"Stickel S","year":"2019","unstructured":"Stickel S, Gin-Sing W, Wagenaar M, Gibbs JSR. The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(Suppl K):K46-K53."},{"issue":"5","key":"b35","series-title":"Hypertension","first-page":"824","article-title":"Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial","volume":"56","author":"Bakris GL","year":"2010","unstructured":"Bakris GL, Lindholm LH, Black HR, Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension. 2010;56(5):824\u2013830."},{"issue":"3","key":"b1","series-title":"Cochrane Database Syst Rev","first-page":"CD000277","article-title":"Calcium antagonists for aneurysmal subarachnoid haemorrhage","volume":"2007","author":"Dorhout Mees SM","year":"2007","unstructured":"Dorhout Mees SM, Rinkel GJ, Feigin VL, Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(3):CD000277."},{"issue":"1","key":"b2","series-title":"Cerebrovasc Dis","first-page":"89","article-title":"Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report","volume":"32","author":"Suzuki S","year":"2011","unstructured":"Suzuki S, Sayama T, Nakamura T, Cilostazol improves outcome after subarachnoid hemorrhage: a preliminary report. Cerebrovasc Dis. 2011;32(1):89\u201393."},{"issue":"4","key":"b3","series-title":"J Neurosurg","first-page":"571","article-title":"Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial","volume":"76","author":"Shibuya M","year":"1992","unstructured":"Shibuya M, Suzuki Y, Sugita K, Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992;76(4):571\u2013577."},{"issue":"2","key":"b4","series-title":"Surg Neurol","first-page":"126","article-title":"A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage","volume":"68","author":"Suzuki Y","year":"2007","unstructured":"Suzuki Y, Shibuya M, Satoh S, Sugimoto Y, Takakura K. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2007;68(2):126\u2013132."},{"issue":"10","key":"b5","series-title":"Stroke","first-page":"3403","article-title":"Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis","volume":"40","author":"Kramer A","year":"2009","unstructured":"Kramer A, Fletcher J. Do endothelin-receptor antagonists prevent delayed neurological deficits and poor outcomes after aneurysmal subarachnoid hemorrhage?: a meta-analysis. Stroke. 2009;40(10):3403\u20133406."},{"issue":"3","key":"b6","series-title":"Clin Auton Res","first-page":"143","article-title":"Endothelin receptor antagonists and cerebral vasospasm","volume":"14","author":"Zimmermann M","year":"2004","unstructured":"Zimmermann M, Seifert V. Endothelin receptor antagonists and cerebral vasospasm. Clin Auton Res. 2004;14(3):143\u2013145."},{"issue":"9","key":"b7","series-title":"Acta Neurochir (Wien)","first-page":"911","article-title":"Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage\u2014preliminary results from a randomized clinical series","volume":"149","author":"Barth M","year":"2007","unstructured":"Barth M, Capelle HH, M\u00fcnch E, Effects of the selective endothelin A (ET(A)) receptor antagonist clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage\u2014preliminary results from a randomized clinical series. Acta Neurochir (Wien). 2007;149(9):911\u2013918."},{"issue":"1-2","key":"b8","series-title":"Cerebrovasc Dis","first-page":"59","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura M","year":"2017","unstructured":"Fujimura M, Joo JY, Kim JS, Hatta M, Yokoyama Y, Tominaga T. Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients. Cerebrovasc Dis. 2017;44(1-2):59\u201367."},{"issue":"6","key":"b9","series-title":"J Neurosurg","first-page":"1707","article-title":"Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients","volume":"137","author":"Endo H","year":"2022","unstructured":"Endo H, Hagihara Y, Kimura N, Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients. J Neurosurg. 2022;137(6):1707\u20131717."},{"issue":"1","key":"b10","series-title":"Neurosurg Rev","first-page":"195","article-title":"Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study","volume":"46","author":"Muraoka S","year":"2023","unstructured":"Muraoka S, Asai T, Fukui T, Real-world data of clazosentan in combination therapy for aneurysmal subarachnoid hemorrhage: a multicenter retrospective cohort study. Neurosurg Rev. 2023;46(1):195."},{"key":"b11","series-title":"Front Neurol","first-page":"1413632","article-title":"Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study","volume":"15","author":"Sakata H","year":"2024","unstructured":"Sakata H, Kanoke A, Uchida H, Prophylactic management of cerebral vasospasm with clazosentan in real clinical practice: a single-center retrospective cohort study. Front Neurol. 2024;15:1413632."},{"issue":"1","key":"b12","series-title":"Neurosurg Rev","first-page":"113","article-title":"Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan","volume":"47","author":"Mochizuki T","year":"2024","unstructured":"Mochizuki T, Ryu B, Shima S, Comparison of efficacy between clazosentan and fasudil hydrochloride-based management of vasospasm after subarachnoid hemorrhage focusing on older and WFNS grade V patients: a single-center experience in Japan. Neurosurg Rev. 2024;47(1):113."},{"issue":"9596","key":"b13","series-title":"Lancet","first-page":"1453","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20131457."},{"issue":"6","key":"b14","series-title":"Stroke","first-page":"1711","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly ES Jr","year":"2012","unstructured":"Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2012;43(6):1711\u20131737."},{"issue":"10","key":"b15","series-title":"Stroke","first-page":"2391","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen MDI","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20132395."},{"issue":"11","key":"b16","series-title":"J Cereb Blood Flow Metab","first-page":"1761","article-title":"Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia","volume":"28","author":"Vergouwen MDI","year":"2008","unstructured":"Vergouwen MDI, Vermeulen M, Coert BA, Stroes ESG, Roos YBWEM. Microthrombosis after aneurysmal subarachnoid hemorrhage: an additional explanation for delayed cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(11):1761\u20131770."},{"key":"b17","article-title":"R: A language and environment for statistical computing. R Foundation for Statistical Computing","unstructured":"R: A language and environment for statistical computing. R Foundation for Statistical Computing. Accessed February 5, 2025. https:\/\/www.R-project.org\/"},{"issue":"12","key":"b18","series-title":"Curr Atheroscler Rep","first-page":"50","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology","volume":"19","author":"Geraghty JR","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50."},{"issue":"2","key":"b19","series-title":"J Pharmacol Exp Ther","first-page":"322","article-title":"Endothelin ETA receptor blockade, by activating ETB receptors, increases vascular permeability and induces exaggerated fluid retention","volume":"361","author":"Vercauteren M","year":"2017","unstructured":"Vercauteren M, Trensz F, Pasquali A, Endothelin ETA receptor blockade, by activating ETB receptors, increases vascular permeability and induces exaggerated fluid retention. J Pharmacol Exp Ther. 2017;361(2):322\u2013333."},{"issue":"6","key":"b20","series-title":"Stroke","first-page":"653","article-title":"Morphometry of brain parenchymal vessels following subarachnoid hemorrhage","volume":"11","author":"Hart MN","year":"1980","unstructured":"Hart MN. Morphometry of brain parenchymal vessels following subarachnoid hemorrhage. Stroke. 1980;11(6):653\u2013655."},{"issue":"6","key":"b21","series-title":"Neurosurgery","first-page":"1152","article-title":"Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage","volume":"61","author":"Udoetuk JD","year":"2007","unstructured":"Udoetuk JD, Stiefel MF, Hurst RW, Weigele JB, LeRoux PD. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;61(6):1152\u20131161."},{"issue":"Pt 7","key":"b22","series-title":"Brain","first-page":"1866","article-title":"Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage","volume":"132","author":"Dreier JP","year":"2009","unstructured":"Dreier JP, Major S, Manning A, Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain. 2009;132(Pt 7):1866-1881."},{"issue":"2","key":"b23","series-title":"J Cereb Blood Flow Metab","first-page":"203","article-title":"Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage","volume":"32","author":"Woitzik J","year":"2012","unstructured":"Woitzik J, Dreier JP, Hecht N, Delayed cerebral ischemia and spreading depolarization in absence of angiographic vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2012;32(2):203\u2013212."},{"issue":"2","key":"b24","series-title":"Brain Hemorrhages","first-page":"62","article-title":"Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage","volume":"5","author":"Suzuki H","year":"2024","unstructured":"Suzuki H, Nakajima H, Ichikawa T, Beneficial effects of clazosentan add-on treatment on delayed cerebral microcirculatory disturbances after aneurysmal subarachnoid hemorrhage. Brain Hemorrhages. 2024;5(2):62\u201368."},{"issue":"11","key":"b25","series-title":"Stroke","first-page":"3015","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald RL","year":"2008","unstructured":"Macdonald RL, Kassell NF, Mayer S, Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke. 2008;39(11):3015\u20133021."},{"issue":"7","key":"b26","series-title":"Lancet Neurol","first-page":"618","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald RL","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10(7):618\u2013625."},{"issue":"6","key":"b27","series-title":"Stroke","first-page":"1463","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald RL","year":"2012","unstructured":"Macdonald RL, Higashida RT, Keller E, Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012;43(6):1463\u20131469."},{"issue":"3","key":"b28","series-title":"J Neurosurg","first-page":"1006","article-title":"Vasospasm: does it cause infarction and poor outcome?","volume":"134","author":"Weir B","year":"2020","unstructured":"Weir B. Vasospasm: does it cause infarction and poor outcome?. J Neurosurg. 2020;134(3):1006\u20131011."},{"issue":"1","key":"b29","series-title":"AJNR Am J Neuroradiol","first-page":"80","article-title":"Transcranial Doppler velocities and angiographic vasospasm after SAH: a diagnostic accuracy study","volume":"43","author":"Darsaut TE","year":"2022","unstructured":"Darsaut TE, Keough MB, Chan AM, Transcranial Doppler velocities and angiographic vasospasm after SAH: a diagnostic accuracy study. AJNR Am J Neuroradiol. 2022;43(1):80\u201386."},{"issue":"10","key":"b30","series-title":"Neurol Med Chir (Tokyo)","first-page":"679","article-title":"Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine","volume":"51","author":"Zhao J","year":"2011","unstructured":"Zhao J, Zhou D, Guo J, Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo). 2011;51(10):679\u2013683."},{"issue":"1","key":"b31","series-title":"J Neurosurg","first-page":"98","article-title":"REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage","volume":"142","author":"Mayer SA","year":"2024","unstructured":"Mayer SA, Bruder N, Citerio G, REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2024;142(1):98\u2013109."},{"issue":"1 Suppl","key":"b32","series-title":"J Am Coll Cardiol","first-page":"S78","article-title":"Updated evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"54","author":"Barst RJ","year":"2009","unstructured":"Barst RJ, Gibbs JSR, Ghofrani HA, Updated evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54(1 Suppl):S78\u2013S84."},{"issue":"12 Suppl S","key":"b33","series-title":"J Am Coll Cardiol","first-page":"81S","article-title":"Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension","volume":"43","author":"Gali\u00e8 N","year":"2004","unstructured":"Gali\u00e8 N, Seeger W, Naeije R, Simonneau G, Rubin LJ. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):81S\u201388S."},{"issue":"Suppl K","key":"b34","series-title":"Eur Heart J Suppl","first-page":"K46","article-title":"The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension","volume":"21","author":"Stickel S","year":"2019","unstructured":"Stickel S, Gin-Sing W, Wagenaar M, Gibbs JSR. The practical management of fluid retention in adults with right heart failure due to pulmonary arterial hypertension. Eur Heart J Suppl. 2019;21(Suppl K):K46-K53."},{"issue":"5","key":"b35","series-title":"Hypertension","first-page":"824","article-title":"Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial","volume":"56","author":"Bakris GL","year":"2010","unstructured":"Bakris GL, Lindholm LH, Black HR, Divergent results using clinic and ambulatory blood pressures: report of a darusentan-resistant hypertension trial. Hypertension. 2010;56(5):824\u2013830."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/143\/3\/article-p624.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/143\/3\/article-p624.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/143\/3\/article-p624.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T14:31:35Z","timestamp":1772721095000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/143\/3\/article-p624.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":70,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3171\/2025.1.jns242509","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}